ANGIODYNAMICS INC
ANGO
Transaktioner
602
Köp
287
Sälj
315
Nettoinsynsflöde
-8.3 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
602 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-07-30 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 23 k | 14,72 | 344 k USD |
| 2026-07-30 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 23 k | 14,72 | 344 k USD |
| 2026-07-22 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 6 k | 0,00 | 0 USD |
| 2026-07-22 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 2 k | 13,82 | 32 k USD |
| 2026-07-22 | Clemmer James C | President and CEO | Buy | 52 k | 0,00 | 0 USD |
| 2026-07-22 | Clemmer James C | President and CEO | Sell | 27 k | 13,82 | 369 k USD |
| 2026-07-22 | Trowbridge Stephen A | EVP and CFO | Buy | 16 k | 0,00 | 0 USD |
| 2026-07-22 | Trowbridge Stephen A | EVP and CFO | Sell | 8 k | 13,82 | 115 k USD |
| 2026-07-22 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 6 k | 0,00 | 0 USD |
| 2026-07-22 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 2 k | 13,82 | 23 k USD |
| 2026-07-22 | Piccinini Laura | SVP International | Buy | 8 k | 0,00 | 0 USD |
| 2026-07-22 | Piccinini Laura | SVP International | Sell | 5 k | 13,82 | 62 k USD |
| 2026-07-22 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 6 k | 0,00 | 0 USD |
| 2026-07-22 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 2 k | 13,82 | 32 k USD |
| 2026-07-22 | Clemmer James C | President and CEO | Buy | 52 k | 0,00 | 0 USD |
| 2026-07-22 | Clemmer James C | President and CEO | Sell | 27 k | 13,82 | 369 k USD |
| 2026-07-22 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 6 k | 0,00 | 0 USD |
| 2026-07-22 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 2 k | 13,82 | 23 k USD |
| 2026-07-22 | Piccinini Laura | SVP International | Buy | 8 k | 0,00 | 0 USD |
| 2026-07-22 | Piccinini Laura | SVP International | Sell | 5 k | 13,82 | 62 k USD |
| 2026-07-22 | Trowbridge Stephen A | EVP and CFO | Buy | 16 k | 0,00 | 0 USD |
| 2026-07-22 | Trowbridge Stephen A | EVP and CFO | Sell | 8 k | 13,82 | 115 k USD |
| 2026-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 359 | 13,71 | 5 k USD |
| 2026-07-20 | Clemmer James C | President and CEO | Sell | 4 k | 13,71 | 58 k USD |
| 2026-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 251 | 13,71 | 3 k USD |
| 2026-07-20 | Piccinini Laura | SVP International | Sell | 616 | 13,71 | 8 k USD |
| 2026-07-20 | Trowbridge Stephen A | EVP and CFO | Sell | 717 | 13,71 | 10 k USD |
| 2026-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 359 | 13,71 | 5 k USD |
| 2026-07-20 | Clemmer James C | President and CEO | Sell | 4 k | 13,71 | 58 k USD |
| 2026-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 251 | 13,71 | 3 k USD |
| 2026-07-20 | Piccinini Laura | SVP International | Sell | 616 | 13,71 | 8 k USD |
| 2026-07-20 | Trowbridge Stephen A | EVP and CFO | Sell | 717 | 13,71 | 10 k USD |
| 2026-07-19 | Clemmer James C | President and CEO | Sell | 12 k | 13,51 | 159 k USD |
| 2026-07-19 | Clemmer James C | President and CEO | Sell | 487 | 13,51 | 7 k USD |
| 2026-07-19 | Clemmer James C | President and CEO | Sell | 12 k | 13,51 | 159 k USD |
| 2026-07-19 | Clemmer James C | President and CEO | Sell | 487 | 13,51 | 7 k USD |
| 2026-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 13,51 | 15 k USD |
| 2026-07-17 | Clemmer James C | President and CEO | Sell | 11 k | 13,51 | 144 k USD |
| 2026-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 1 k | 13,51 | 19 k USD |
| 2026-07-17 | Piccinini Laura | SVP International | Sell | 3 k | 13,51 | 42 k USD |
| 2026-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 4 k | 13,51 | 47 k USD |
| 2026-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 13,51 | 15 k USD |
| 2026-07-17 | Clemmer James C | President and CEO | Sell | 11 k | 13,51 | 144 k USD |
| 2026-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 1 k | 13,51 | 19 k USD |
| 2026-07-17 | Piccinini Laura | SVP International | Sell | 3 k | 13,51 | 42 k USD |
| 2026-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 4 k | 13,51 | 47 k USD |
| 2026-07-16 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 2 k | 14,14 | 33 k USD |
| 2026-07-16 | Clemmer James C | President and CEO | Sell | 19 k | 14,14 | 263 k USD |
| 2026-07-16 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 2 k | 14,14 | 30 k USD |
| 2026-07-16 | Piccinini Laura | SVP International | Sell | 5 k | 14,14 | 64 k USD |
| 2026-07-16 | Trowbridge Stephen A | EVP and CFO | Sell | 8 k | 14,14 | 111 k USD |
| 2026-07-16 | Weiss Lawrence T | SVP, Chief Legal Officer | Sell | 2 k | 14,14 | 32 k USD |
| 2026-07-16 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 2 k | 14,14 | 33 k USD |
| 2026-07-16 | Clemmer James C | President and CEO | Sell | 19 k | 14,14 | 263 k USD |
| 2026-07-16 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 2 k | 14,14 | 30 k USD |
| 2026-07-16 | Piccinini Laura | SVP International | Sell | 5 k | 14,14 | 64 k USD |
| 2026-07-16 | Trowbridge Stephen A | EVP and CFO | Sell | 8 k | 14,14 | 111 k USD |
| 2026-07-16 | Weiss Lawrence T | SVP, Chief Legal Officer | Sell | 2 k | 14,14 | 32 k USD |
| 2026-07-15 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 21 k | 0,00 | 0 USD |
| 2026-07-15 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 16 k | 0,00 | 0 USD |
| 2026-07-15 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 18 k | 0,00 | 0 USD |
| 2026-07-15 | Piccinini Laura | SVP International | Buy | 20 k | 0,00 | 0 USD |
| 2026-07-15 | Trowbridge Stephen A | EVP and CFO | Buy | 53 k | 0,00 | 0 USD |
| 2026-07-15 | Tarnoff Michael E | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Auen Eileen O'Shea | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Burgess Lorinda | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | DONNELLY HOWARD W | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | JOHNSON WESLEY | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Licitra Karen A | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | REED JAN STERN | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Auen Eileen O'Shea | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Burgess Lorinda | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 16 k | 0,00 | 0 USD |
| 2026-07-15 | DONNELLY HOWARD W | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | JOHNSON WESLEY | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Licitra Karen A | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 18 k | 0,00 | 0 USD |
| 2026-07-15 | Piccinini Laura | SVP International | Buy | 20 k | 0,00 | 0 USD |
| 2026-07-15 | REED JAN STERN | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Tarnoff Michael E | Director | Buy | 12 k | 0,00 | 0 USD |
| 2026-07-15 | Trowbridge Stephen A | EVP and CFO | Buy | 53 k | 0,00 | 0 USD |
| 2026-07-15 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 21 k | 0,00 | 0 USD |
| 2025-10-21 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 10 k | 11,81 | 118 k USD |
| 2025-10-21 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 10 k | 11,81 | 118 k USD |
| 2025-10-13 | Trowbridge Stephen A | EVP and CFO | Buy | 890 | 11,16 | 10 k USD |
| 2025-10-13 | Trowbridge Stephen A | EVP and CFO | Buy | 890 | 11,16 | 10 k USD |
| 2025-10-09 | Clemmer James C | President and CEO | Buy | 10 k | 11,15 | 112 k USD |
| 2025-10-09 | Clemmer James C | President and CEO | Buy | 10 k | 11,15 | 112 k USD |
| 2025-07-21 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 395 | 8,99 | 4 k USD |
| 2025-07-21 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 277 | 8,99 | 2 k USD |
| 2025-07-21 | Trowbridge Stephen A | EVP and CFO | Sell | 667 | 8,99 | 6 k USD |
| 2025-07-21 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 395 | 8,99 | 4 k USD |
| 2025-07-21 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 277 | 8,99 | 2 k USD |
| 2025-07-21 | Trowbridge Stephen A | EVP and CFO | Sell | 667 | 8,99 | 6 k USD |
| 2025-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 359 | 8,69 | 3 k USD |
| 2025-07-20 | Clemmer James C | President and CEO | Sell | 3 k | 8,69 | 26 k USD |
| 2025-07-20 | Clemmer James C | President and CEO | Sell | 4 k | 8,99 | 33 k USD |
| 2025-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 251 | 8,69 | 2 k USD |
| 2025-07-20 | Piccinini Laura | SVP International | Sell | 616 | 8,69 | 5 k USD |
| 2025-07-20 | Trowbridge Stephen A | EVP and CFO | Sell | 717 | 8,69 | 6 k USD |
| 2025-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 359 | 8,69 | 3 k USD |
| 2025-07-20 | Clemmer James C | President and CEO | Sell | 3 k | 8,69 | 26 k USD |
| 2025-07-20 | Clemmer James C | President and CEO | Sell | 4 k | 8,99 | 33 k USD |
| 2025-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 251 | 8,69 | 2 k USD |
| 2025-07-20 | Piccinini Laura | SVP International | Sell | 616 | 8,69 | 5 k USD |
| 2025-07-20 | Trowbridge Stephen A | EVP and CFO | Sell | 717 | 8,69 | 6 k USD |
| 2025-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 8,69 | 9 k USD |
| 2025-07-19 | Clemmer James C | President and CEO | Sell | 344 | 8,69 | 3 k USD |
| 2025-07-19 | Clemmer James C | President and CEO | Sell | 8 k | 8,69 | 72 k USD |
| 2025-07-19 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 735 | 8,69 | 6 k USD |
| 2025-07-19 | Piccinini Laura | SVP International | Sell | 2 k | 8,69 | 17 k USD |
| 2025-07-19 | Trowbridge Stephen A | EVP and CFO | Sell | 3 k | 8,69 | 22 k USD |
| 2025-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 8,69 | 9 k USD |
| 2025-07-19 | Clemmer James C | President and CEO | Sell | 344 | 8,69 | 3 k USD |
| 2025-07-19 | Clemmer James C | President and CEO | Sell | 8 k | 8,69 | 72 k USD |
| 2025-07-19 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 735 | 8,69 | 6 k USD |
| 2025-07-19 | Piccinini Laura | SVP International | Sell | 2 k | 8,69 | 17 k USD |
| 2025-07-19 | Trowbridge Stephen A | EVP and CFO | Sell | 3 k | 8,69 | 22 k USD |
| 2025-07-17 | Piccinini Laura | SVP International | Sell | 3 k | 8,74 | 27 k USD |
| 2025-07-17 | Piccinini Laura | SVP International | Sell | 3 k | 8,74 | 27 k USD |
| 2025-07-16 | JOHNSON WESLEY | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Licitra Karen A | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | REED JAN STERN | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Tarnoff Michael E | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Auen Eileen O'Shea | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Burgess Lorinda | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | DONNELLY HOWARD W | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 26 k | 0,00 | 0 USD |
| 2025-07-16 | Trowbridge Stephen A | EVP and CFO | Buy | 87 k | 0,00 | 0 USD |
| 2025-07-16 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 31 k | 0,00 | 0 USD |
| 2025-07-16 | Clemmer James C | President and CEO | Buy | 206 k | 0,00 | 0 USD |
| 2025-07-16 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 29 k | 0,00 | 0 USD |
| 2025-07-16 | Piccinini Laura | SVP International | Buy | 32 k | 0,00 | 0 USD |
| 2025-07-16 | Auen Eileen O'Shea | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Burgess Lorinda | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 26 k | 0,00 | 0 USD |
| 2025-07-16 | Clemmer James C | President and CEO | Buy | 206 k | 0,00 | 0 USD |
| 2025-07-16 | DONNELLY HOWARD W | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | JOHNSON WESLEY | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Licitra Karen A | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 29 k | 0,00 | 0 USD |
| 2025-07-16 | Piccinini Laura | SVP International | Buy | 32 k | 0,00 | 0 USD |
| 2025-07-16 | REED JAN STERN | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Tarnoff Michael E | Director | Buy | 18 k | 0,00 | 0 USD |
| 2025-07-16 | Trowbridge Stephen A | EVP and CFO | Buy | 87 k | 0,00 | 0 USD |
| 2025-07-16 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 31 k | 0,00 | 0 USD |
| 2025-01-16 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 4 k | 12,31 | 50 k USD |
| 2025-01-16 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 4 k | 12,31 | 50 k USD |
| 2024-12-02 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 53 k | 0,00 | 0 USD |
| 2024-12-02 | Weiss Lawrence T | SVP, Chief Legal Officer | Buy | 53 k | 0,00 | 0 USD |
| 2024-10-10 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 100 | 6,08 | 608 USD |
| 2024-10-10 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 100 | 6,08 | 608 USD |
| 2024-10-08 | Trowbridge Stephen A | EVP and CFO | Buy | 2 k | 5,86 | 10 k USD |
| 2024-10-08 | Trowbridge Stephen A | EVP and CFO | Buy | 2 k | 5,86 | 10 k USD |
| 2024-10-07 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 768 | 6,09 | 5 k USD |
| 2024-10-07 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 768 | 6,09 | 5 k USD |
| 2024-10-07 | Clemmer James C | President and CEO | Buy | 20 k | 6,03 | 121 k USD |
| 2024-10-07 | Clemmer James C | President and CEO | Buy | 20 k | 6,03 | 121 k USD |
| 2024-07-21 | Trowbridge Stephen A | EVP and CFO | Sell | 667 | 7,13 | 5 k USD |
| 2024-07-21 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 277 | 7,13 | 2 k USD |
| 2024-07-21 | Clemmer James C | President and CEO | Sell | 3 k | 7,13 | 24 k USD |
| 2024-07-21 | Piccinini Laura | SVP International | Sell | 413 | 7,13 | 3 k USD |
| 2024-07-21 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 395 | 7,13 | 3 k USD |
| 2024-07-21 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 395 | 7,13 | 3 k USD |
| 2024-07-21 | Clemmer James C | President and CEO | Sell | 3 k | 7,13 | 24 k USD |
| 2024-07-21 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 277 | 7,13 | 2 k USD |
| 2024-07-21 | Piccinini Laura | SVP International | Sell | 413 | 7,13 | 3 k USD |
| 2024-07-21 | Trowbridge Stephen A | EVP and CFO | Sell | 667 | 7,13 | 5 k USD |
| 2024-07-20 | Trowbridge Stephen A | EVP and CFO | Sell | 717 | 7,13 | 5 k USD |
| 2024-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 251 | 7,13 | 2 k USD |
| 2024-07-20 | Clemmer James C | President and CEO | Sell | 3 k | 7,13 | 21 k USD |
| 2024-07-20 | Piccinini Laura | SVP International | Sell | 616 | 7,13 | 4 k USD |
| 2024-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 359 | 7,13 | 3 k USD |
| 2024-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 359 | 7,13 | 3 k USD |
| 2024-07-20 | Clemmer James C | President and CEO | Sell | 3 k | 7,13 | 21 k USD |
| 2024-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 251 | 7,13 | 2 k USD |
| 2024-07-20 | Piccinini Laura | SVP International | Sell | 616 | 7,13 | 4 k USD |
| 2024-07-20 | Trowbridge Stephen A | EVP and CFO | Sell | 717 | 7,13 | 5 k USD |
| 2024-07-19 | Trowbridge Stephen A | EVP and CFO | Sell | 3 k | 7,18 | 19 k USD |
| 2024-07-19 | Trowbridge Stephen A | EVP and CFO | Sell | 3 k | 7,18 | 19 k USD |
| 2024-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 7,18 | 7 k USD |
| 2024-07-19 | Clemmer James C | President and CEO | Sell | 8 k | 7,18 | 60 k USD |
| 2024-07-19 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 735 | 7,18 | 5 k USD |
| 2024-07-19 | Piccinini Laura | SVP International | Sell | 2 k | 7,18 | 14 k USD |
| 2024-07-19 | Clemmer James C | President and CEO | Buy | 4 k | 0,00 | 0 USD |
| 2024-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 7,18 | 7 k USD |
| 2024-07-19 | Clemmer James C | President and CEO | Sell | 8 k | 7,18 | 60 k USD |
| 2024-07-19 | Clemmer James C | President and CEO | Buy | 4 k | 0,00 | 0 USD |
| 2024-07-19 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 735 | 7,18 | 5 k USD |
| 2024-07-19 | Piccinini Laura | SVP International | Sell | 2 k | 7,18 | 14 k USD |
| 2024-07-17 | Trowbridge Stephen A | EVP and CFO | Buy | 11 k | 0,00 | 0 USD |
| 2024-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 4 k | 7,40 | 30 k USD |
| 2024-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 7 k | 0,00 | 0 USD |
| 2024-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 2 k | 7,40 | 18 k USD |
| 2024-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 6 k | 0,00 | 0 USD |
| 2024-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 2 k | 7,40 | 12 k USD |
| 2024-07-17 | Clemmer James C | President and CEO | Buy | 56 k | 0,00 | 0 USD |
| 2024-07-17 | Clemmer James C | President and CEO | Sell | 29 k | 7,40 | 213 k USD |
| 2024-07-17 | Piccinini Laura | SVP International | Buy | 4 k | 0,00 | 0 USD |
| 2024-07-17 | Piccinini Laura | SVP International | Sell | 2 k | 7,40 | 18 k USD |
| 2024-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 7 k | 0,00 | 0 USD |
| 2024-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 2 k | 7,40 | 18 k USD |
| 2024-07-17 | Clemmer James C | President and CEO | Buy | 56 k | 0,00 | 0 USD |
| 2024-07-17 | Clemmer James C | President and CEO | Sell | 29 k | 7,40 | 213 k USD |
| 2024-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 6 k | 0,00 | 0 USD |
| 2024-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 2 k | 7,40 | 12 k USD |
| 2024-07-17 | Piccinini Laura | SVP International | Buy | 4 k | 0,00 | 0 USD |
| 2024-07-17 | Piccinini Laura | SVP International | Sell | 2 k | 7,40 | 18 k USD |
| 2024-07-17 | Trowbridge Stephen A | EVP and CFO | Buy | 11 k | 0,00 | 0 USD |
| 2024-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 4 k | 7,40 | 30 k USD |
| 2024-07-17 | Auen Eileen O'Shea | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Licitra Karen A | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Trowbridge Stephen A | EVP and CFO | Buy | 39 k | 0,00 | 0 USD |
| 2024-07-17 | Burgess Lorinda | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | DONNELLY HOWARD W | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | JOHNSON WESLEY | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | REED JAN STERN | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 19 k | 0,00 | 0 USD |
| 2024-07-17 | Clemmer James C | President and CEO | Buy | 106 k | 0,00 | 0 USD |
| 2024-07-17 | Tarnoff Michael E | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 12 k | 0,00 | 0 USD |
| 2024-07-17 | Piccinini Laura | SVP International | Buy | 22 k | 0,00 | 0 USD |
| 2024-07-17 | Auen Eileen O'Shea | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Burgess Lorinda | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 12 k | 0,00 | 0 USD |
| 2024-07-17 | Clemmer James C | President and CEO | Buy | 106 k | 0,00 | 0 USD |
| 2024-07-17 | DONNELLY HOWARD W | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | JOHNSON WESLEY | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Licitra Karen A | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 19 k | 0,00 | 0 USD |
| 2024-07-17 | Piccinini Laura | SVP International | Buy | 22 k | 0,00 | 0 USD |
| 2024-07-17 | REED JAN STERN | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Tarnoff Michael E | Director | Buy | 21 k | 0,00 | 0 USD |
| 2024-07-17 | Trowbridge Stephen A | EVP and CFO | Buy | 39 k | 0,00 | 0 USD |
| 2024-04-08 | Clemmer James C | President and CEO | Buy | 10 k | 6,70 | 67 k USD |
| 2024-04-08 | Clemmer James C | President and CEO | Buy | 10 k | 6,70 | 67 k USD |
| 2024-02-29 | Trowbridge Stephen A | EVP and CFO | Buy | 2 k | 4,67 | 9 k USD |
| 2024-02-29 | Trowbridge Stephen A | EVP and CFO | Buy | 2 k | 4,67 | 9 k USD |
| 2023-07-21 | Piccinini Laura | SVP International | Sell | 413 | 8,65 | 4 k USD |
| 2023-07-21 | Centea Scott | SVP/GM, VIT | Sell | 255 | 8,65 | 2 k USD |
| 2023-07-21 | Helsel Dave | SVP Global Operations and R&D | Sell | 365 | 8,65 | 3 k USD |
| 2023-07-21 | Clemmer James C | President and CEO | Sell | 3 k | 8,65 | 29 k USD |
| 2023-07-21 | Trowbridge Stephen A | EVP and CFO | Sell | 667 | 8,65 | 6 k USD |
| 2023-07-21 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 395 | 8,65 | 3 k USD |
| 2023-07-21 | Centea Scott | SVP/GM, VIT | Sell | 255 | 8,65 | 2 k USD |
| 2023-07-21 | Clemmer James C | President and CEO | Sell | 3 k | 8,65 | 29 k USD |
| 2023-07-21 | Helsel Dave | SVP Global Operations and R&D | Sell | 365 | 8,65 | 3 k USD |
| 2023-07-21 | Piccinini Laura | SVP International | Sell | 413 | 8,65 | 4 k USD |
| 2023-07-21 | Trowbridge Stephen A | EVP and CFO | Sell | 667 | 8,65 | 6 k USD |
| 2023-07-20 | Piccinini Laura | SVP International | Sell | 616 | 8,74 | 5 k USD |
| 2023-07-20 | Centea Scott | SVP/GM, VIT | Sell | 333 | 8,74 | 3 k USD |
| 2023-07-20 | Helsel Dave | SVP Global Operations and R&D | Sell | 332 | 8,74 | 3 k USD |
| 2023-07-20 | Clemmer James C | President and CEO | Sell | 3 k | 8,74 | 26 k USD |
| 2023-07-20 | Trowbridge Stephen A | EVP and CFO | Sell | 717 | 8,74 | 6 k USD |
| 2023-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 359 | 8,74 | 3 k USD |
| 2023-07-20 | Centea Scott | SVP/GM, VIT | Sell | 333 | 8,74 | 3 k USD |
| 2023-07-20 | Clemmer James C | President and CEO | Sell | 3 k | 8,74 | 26 k USD |
| 2023-07-20 | Helsel Dave | SVP Global Operations and R&D | Sell | 332 | 8,74 | 3 k USD |
| 2023-07-20 | Piccinini Laura | SVP International | Sell | 616 | 8,74 | 5 k USD |
| 2023-07-20 | Trowbridge Stephen A | EVP and CFO | Sell | 717 | 8,74 | 6 k USD |
| 2023-07-19 | Trowbridge Stephen A | EVP and CFO | Buy | 9 k | 0,00 | 0 USD |
| 2023-07-19 | Trowbridge Stephen A | EVP and CFO | Sell | 3 k | 8,92 | 28 k USD |
| 2023-07-19 | Centea Scott | SVP/GM, VIT | Buy | 3 k | 0,00 | 0 USD |
| 2023-07-19 | Centea Scott | SVP/GM, VIT | Sell | 1 k | 8,92 | 11 k USD |
| 2023-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 4 k | 0,00 | 0 USD |
| 2023-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 8,92 | 13 k USD |
| 2023-07-19 | Helsel Dave | SVP Global Operations and R&D | Buy | 4 k | 0,00 | 0 USD |
| 2023-07-19 | Helsel Dave | SVP Global Operations and R&D | Sell | 2 k | 8,92 | 14 k USD |
| 2023-07-19 | Clemmer James C | President and CEO | Buy | 32 k | 0,00 | 0 USD |
| 2023-07-19 | Clemmer James C | President and CEO | Sell | 11 k | 8,92 | 102 k USD |
| 2023-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 4 k | 0,00 | 0 USD |
| 2023-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 8,92 | 13 k USD |
| 2023-07-19 | Centea Scott | SVP/GM, VIT | Buy | 3 k | 0,00 | 0 USD |
| 2023-07-19 | Centea Scott | SVP/GM, VIT | Sell | 1 k | 8,92 | 11 k USD |
| 2023-07-19 | Clemmer James C | President and CEO | Buy | 32 k | 0,00 | 0 USD |
| 2023-07-19 | Clemmer James C | President and CEO | Sell | 11 k | 8,92 | 102 k USD |
| 2023-07-19 | Helsel Dave | SVP Global Operations and R&D | Buy | 4 k | 0,00 | 0 USD |
| 2023-07-19 | Helsel Dave | SVP Global Operations and R&D | Sell | 2 k | 8,92 | 14 k USD |
| 2023-07-19 | Trowbridge Stephen A | EVP and CFO | Buy | 9 k | 0,00 | 0 USD |
| 2023-07-19 | Trowbridge Stephen A | EVP and CFO | Sell | 3 k | 8,92 | 28 k USD |
| 2023-07-19 | Burgess Lorinda | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Licitra Karen A | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Tarnoff Michael E | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Auen Eileen O'Shea | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | REED JAN STERN | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | DONNELLY HOWARD W | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | JOHNSON WESLEY | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Meteny Dennis S | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Trowbridge Stephen A | EVP and CFO | Buy | 29 k | 0,00 | 0 USD |
| 2023-07-19 | Centea Scott | SVP/GM, VIT | Buy | 11 k | 0,00 | 0 USD |
| 2023-07-19 | Piccinini Laura | SVP International | Buy | 14 k | 0,00 | 0 USD |
| 2023-07-19 | Clemmer James C | President and CEO | Buy | 92 k | 0,00 | 0 USD |
| 2023-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 11 k | 0,00 | 0 USD |
| 2023-07-19 | Helsel Dave | SVP Global Operations and R&D | Buy | 11 k | 0,00 | 0 USD |
| 2023-07-19 | Auen Eileen O'Shea | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Burgess Lorinda | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 11 k | 0,00 | 0 USD |
| 2023-07-19 | Centea Scott | SVP/GM, VIT | Buy | 11 k | 0,00 | 0 USD |
| 2023-07-19 | Clemmer James C | President and CEO | Buy | 92 k | 0,00 | 0 USD |
| 2023-07-19 | DONNELLY HOWARD W | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Helsel Dave | SVP Global Operations and R&D | Buy | 11 k | 0,00 | 0 USD |
| 2023-07-19 | JOHNSON WESLEY | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Licitra Karen A | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Meteny Dennis S | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Piccinini Laura | SVP International | Buy | 14 k | 0,00 | 0 USD |
| 2023-07-19 | REED JAN STERN | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Tarnoff Michael E | Director | Buy | 17 k | 0,00 | 0 USD |
| 2023-07-19 | Trowbridge Stephen A | EVP and CFO | Buy | 29 k | 0,00 | 0 USD |
| 2023-07-17 | Helsel Dave | SVP Global Operations and R&D | Sell | 313 | 9,56 | 3 k USD |
| 2023-07-17 | Centea Scott | SVP/GM, VIT | Sell | 351 | 9,56 | 3 k USD |
| 2023-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 279 | 9,56 | 3 k USD |
| 2023-07-17 | Clemmer James C | President and CEO | Sell | 2 k | 9,56 | 22 k USD |
| 2023-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 376 | 9,56 | 4 k USD |
| 2023-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 279 | 9,56 | 3 k USD |
| 2023-07-17 | Centea Scott | SVP/GM, VIT | Sell | 351 | 9,56 | 3 k USD |
| 2023-07-17 | Clemmer James C | President and CEO | Sell | 2 k | 9,56 | 22 k USD |
| 2023-07-17 | Helsel Dave | SVP Global Operations and R&D | Sell | 313 | 9,56 | 3 k USD |
| 2023-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 376 | 9,56 | 4 k USD |
| 2023-07-14 | Helsel Dave | SVP Global Operations and R&D | Sell | 679 | 9,63 | 7 k USD |
| 2023-07-14 | Centea Scott | SVP/GM, VIT | Sell | 517 | 9,63 | 5 k USD |
| 2023-07-14 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 596 | 9,63 | 6 k USD |
| 2023-07-14 | Clemmer James C | President and CEO | Sell | 5 k | 9,63 | 47 k USD |
| 2023-07-14 | Trowbridge Stephen A | EVP and CFO | Sell | 1 k | 9,63 | 13 k USD |
| 2023-07-14 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 596 | 9,63 | 6 k USD |
| 2023-07-14 | Centea Scott | SVP/GM, VIT | Sell | 517 | 9,63 | 5 k USD |
| 2023-07-14 | Clemmer James C | President and CEO | Sell | 5 k | 9,63 | 47 k USD |
| 2023-07-14 | Helsel Dave | SVP Global Operations and R&D | Sell | 679 | 9,63 | 7 k USD |
| 2023-07-14 | Trowbridge Stephen A | EVP and CFO | Sell | 1 k | 9,63 | 13 k USD |
| 2023-06-01 | Piccinini Laura | SVP International | Sell | 1 k | 9,64 | 13 k USD |
| 2023-06-01 | Piccinini Laura | SVP International | Sell | 1 k | 9,64 | 13 k USD |
| 2023-02-03 | Trowbridge Stephen A | EVP and CFO | Sell | 555 | 13,43 | 7 k USD |
| 2023-02-03 | Trowbridge Stephen A | EVP and CFO | Sell | 555 | 13,43 | 7 k USD |
| 2023-02-01 | ROSENZWEIG RICHARD C | SVP and General Counsel | Sell | 1 k | 13,36 | 15 k USD |
| 2023-02-01 | ROSENZWEIG RICHARD C | SVP and General Counsel | Sell | 1 k | 13,36 | 15 k USD |
| 2023-01-31 | Helsel Dave | SVP Global Operations and R&D | Sell | 5 k | 12,95 | 60 k USD |
| 2023-01-31 | Helsel Dave | SVP Global Operations and R&D | Sell | 5 k | 12,95 | 60 k USD |
| 2022-10-12 | Trowbridge Stephen A | EVP and CFO | Buy | 1 k | 13,82 | 15 k USD |
| 2022-10-12 | Trowbridge Stephen A | EVP and CFO | Buy | 1 k | 13,82 | 15 k USD |
| 2022-10-10 | Clemmer James C | President and CEO | Buy | 10 k | 15,00 | 150 k USD |
| 2022-10-10 | Clemmer James C | President and CEO | Buy | 10 k | 15,00 | 150 k USD |
| 2022-07-29 | Helsel Dave | SVP Global Operations and R&D | Sell | 5 k | 22,44 | 112 k USD |
| 2022-07-29 | Helsel Dave | SVP Global Operations and R&D | Sell | 5 k | 22,44 | 112 k USD |
| 2022-07-20 | Auen Eileen O'Shea | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | REED JAN STERN | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Meteny Dennis S | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | JOHNSON WESLEY | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | DONNELLY HOWARD W | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Licitra Karen A | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Tarnoff Michael E | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Centea Scott | SVP/GM, VIT | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | Trowbridge Stephen A | EVP and CFO | Buy | 8 k | 0,00 | 0 USD |
| 2022-07-20 | ROSENZWEIG RICHARD C | SVP and General Counsel | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | Piccinini Laura | SVP International | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | Helsel Dave | SVP Global Operations and R&D | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 3 k | 0,00 | 0 USD |
| 2022-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | Clemmer James C | President and CEO | Buy | 33 k | 0,00 | 0 USD |
| 2022-07-20 | Auen Eileen O'Shea | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | Centea Scott | SVP/GM, VIT | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | Clemmer James C | President and CEO | Buy | 33 k | 0,00 | 0 USD |
| 2022-07-20 | DONNELLY HOWARD W | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Helsel Dave | SVP Global Operations and R&D | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | JOHNSON WESLEY | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Licitra Karen A | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Meteny Dennis S | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 3 k | 0,00 | 0 USD |
| 2022-07-20 | Piccinini Laura | SVP International | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | REED JAN STERN | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | ROSENZWEIG RICHARD C | SVP and General Counsel | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-20 | Tarnoff Michael E | Director | Buy | 7 k | 0,00 | 0 USD |
| 2022-07-20 | Trowbridge Stephen A | EVP and CFO | Buy | 8 k | 0,00 | 0 USD |
| 2022-07-15 | Trowbridge Stephen A | EVP and CFO | Buy | 15 k | 15,95 | 235 k USD |
| 2022-07-15 | Trowbridge Stephen A | EVP and CFO | Sell | 12 k | 21,32 | 264 k USD |
| 2022-07-15 | JOHNSON WESLEY | Director | Buy | 6 k | 15,95 | 96 k USD |
| 2022-07-15 | JOHNSON WESLEY | Director | Sell | 5 k | 21,32 | 96 k USD |
| 2022-07-15 | JOHNSON WESLEY | Director | Buy | 6 k | 15,95 | 96 k USD |
| 2022-07-15 | JOHNSON WESLEY | Director | Sell | 5 k | 21,32 | 96 k USD |
| 2022-07-15 | Trowbridge Stephen A | EVP and CFO | Buy | 15 k | 15,95 | 235 k USD |
| 2022-07-15 | Trowbridge Stephen A | EVP and CFO | Sell | 12 k | 21,32 | 264 k USD |
| 2022-07-12 | Meteny Dennis S | Director | Buy | 6 k | 15,95 | 96 k USD |
| 2022-07-12 | Meteny Dennis S | Director | Sell | 5 k | 20,02 | 96 k USD |
| 2022-07-12 | Meteny Dennis S | Director | Buy | 6 k | 15,95 | 96 k USD |
| 2022-07-12 | Meteny Dennis S | Director | Sell | 5 k | 20,02 | 96 k USD |
| 2022-07-07 | Clemmer James C | President and CEO | Buy | 25 k | 0,00 | 0 USD |
| 2022-07-07 | Clemmer James C | President and CEO | Sell | 9 k | 20,54 | 176 k USD |
| 2022-07-07 | Trowbridge Stephen A | EVP and CFO | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-07 | Trowbridge Stephen A | EVP and CFO | Sell | 2 k | 20,54 | 31 k USD |
| 2022-07-07 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 3 k | 0,00 | 0 USD |
| 2022-07-07 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 919 | 20,54 | 19 k USD |
| 2022-07-07 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 3 k | 0,00 | 0 USD |
| 2022-07-07 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 20,54 | 22 k USD |
| 2022-07-07 | Helsel Dave | SVP Global Operations and R&D | Buy | 3 k | 0,00 | 0 USD |
| 2022-07-07 | Helsel Dave | SVP Global Operations and R&D | Sell | 1 k | 20,54 | 25 k USD |
| 2022-07-07 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 3 k | 0,00 | 0 USD |
| 2022-07-07 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 1 k | 20,54 | 22 k USD |
| 2022-07-07 | Clemmer James C | President and CEO | Buy | 25 k | 0,00 | 0 USD |
| 2022-07-07 | Clemmer James C | President and CEO | Sell | 9 k | 20,54 | 176 k USD |
| 2022-07-07 | Helsel Dave | SVP Global Operations and R&D | Buy | 3 k | 0,00 | 0 USD |
| 2022-07-07 | Helsel Dave | SVP Global Operations and R&D | Sell | 1 k | 20,54 | 25 k USD |
| 2022-07-07 | Nighan Warren JR | SVP Quality and Regulatory | Buy | 3 k | 0,00 | 0 USD |
| 2022-07-07 | Nighan Warren JR | SVP Quality and Regulatory | Sell | 919 | 20,54 | 19 k USD |
| 2022-07-07 | Trowbridge Stephen A | EVP and CFO | Buy | 4 k | 0,00 | 0 USD |
| 2022-07-07 | Trowbridge Stephen A | EVP and CFO | Sell | 2 k | 20,54 | 31 k USD |
| 2022-04-28 | Helsel Dave | SVP Global Operations and R&D | Sell | 4 k | 22,44 | 79 k USD |
| 2022-04-28 | Helsel Dave | SVP Global Operations and R&D | Sell | 4 k | 22,44 | 79 k USD |
| 2022-04-20 | DONNELLY HOWARD W | Director | Buy | 6 k | 15,95 | 96 k USD |
| 2022-04-20 | DONNELLY HOWARD W | Director | Buy | 6 k | 15,95 | 96 k USD |
| 2022-04-12 | JOHNSON WESLEY | Director | Sell | 1 k | 23,26 | 30 k USD |
| 2022-04-12 | JOHNSON WESLEY | Director | Sell | 1 k | 23,26 | 30 k USD |
| 2022-04-11 | JOHNSON WESLEY | Director | Sell | 6 k | 23,00 | 143 k USD |
| 2022-04-11 | JOHNSON WESLEY | Director | Sell | 6 k | 23,00 | 143 k USD |
| 2022-02-03 | Trowbridge Stephen A | EVP and CFO | Sell | 583 | 20,48 | 12 k USD |
| 2022-02-03 | Trowbridge Stephen A | EVP and CFO | Sell | 583 | 20,48 | 12 k USD |
| 2022-02-01 | ROSENZWEIG RICHARD C | SVP and General Counsel | Sell | 1 k | 21,31 | 25 k USD |
| 2022-02-01 | ROSENZWEIG RICHARD C | SVP and General Counsel | Sell | 1 k | 21,31 | 25 k USD |
| 2022-01-12 | Trowbridge Stephen A | EVP and CFO | Buy | 1 k | 22,64 | 23 k USD |
| 2022-01-12 | Trowbridge Stephen A | EVP and CFO | Buy | 1 k | 22,64 | 23 k USD |
| 2022-01-11 | Clemmer James C | President and CEO | Buy | 10 k | 22,84 | 228 k USD |
| 2022-01-11 | Clemmer James C | President and CEO | Buy | 10 k | 22,84 | 228 k USD |
| 2021-10-31 | Centea Scott | Sr. VP/GM, Global VIT | Sell | 953 | 29,37 | 28 k USD |
| 2021-10-31 | Centea Scott | Sr. VP/GM, Global VIT | Sell | 953 | 29,37 | 28 k USD |
| 2021-10-20 | Helsel Dave | SVP Global Operations and R&D | Sell | 3 k | 27,97 | 98 k USD |
| 2021-10-20 | Helsel Dave | SVP Global Operations and R&D | Sell | 3 k | 27,97 | 98 k USD |
| 2021-10-15 | Centea Scott | Sr. VP/GM, Global VIT | Buy | 12 k | 16,77 | 201 k USD |
| 2021-10-15 | Centea Scott | Sr. VP/GM, Global VIT | Sell | 12 k | 27,92 | 335 k USD |
| 2021-10-15 | Centea Scott | Sr. VP/GM, Global VIT | Buy | 12 k | 16,77 | 201 k USD |
| 2021-10-15 | Centea Scott | Sr. VP/GM, Global VIT | Sell | 12 k | 27,92 | 335 k USD |
| 2021-10-05 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 11 k | 16,59 | 178 k USD |
| 2021-10-05 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 11 k | 27,15 | 292 k USD |
| 2021-10-05 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 11 k | 16,59 | 178 k USD |
| 2021-10-05 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 11 k | 27,15 | 292 k USD |
| 2021-08-12 | Trowbridge Stephen A | EVP and CFO | Buy | 3 k | 0,00 | 0 USD |
| 2021-08-12 | Trowbridge Stephen A | EVP and CFO | Sell | 1 k | 27,29 | 34 k USD |
| 2021-08-12 | Clemmer James C | President and CEO | Buy | 19 k | 0,00 | 0 USD |
| 2021-08-12 | Clemmer James C | President and CEO | Sell | 9 k | 27,29 | 246 k USD |
| 2021-08-12 | Helsel Dave | SVP Global Operations and R&D | Buy | 3 k | 0,00 | 0 USD |
| 2021-08-12 | Helsel Dave | SVP Global Operations and R&D | Sell | 788 | 27,29 | 22 k USD |
| 2021-08-12 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 2 k | 0,00 | 0 USD |
| 2021-08-12 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 702 | 27,29 | 19 k USD |
| 2021-08-12 | Clemmer James C | President and CEO | Buy | 19 k | 0,00 | 0 USD |
| 2021-08-12 | Clemmer James C | President and CEO | Sell | 9 k | 27,29 | 246 k USD |
| 2021-08-12 | Helsel Dave | SVP Global Operations and R&D | Buy | 3 k | 0,00 | 0 USD |
| 2021-08-12 | Helsel Dave | SVP Global Operations and R&D | Sell | 788 | 27,29 | 22 k USD |
| 2021-08-12 | Trowbridge Stephen A | EVP and CFO | Buy | 3 k | 0,00 | 0 USD |
| 2021-08-12 | Trowbridge Stephen A | EVP and CFO | Sell | 1 k | 27,29 | 34 k USD |
| 2021-07-28 | JOHNSON WESLEY | Director | Buy | 6 k | 14,64 | 84 k USD |
| 2021-07-28 | JOHNSON WESLEY | Director | Sell | 3 k | 26,43 | 84 k USD |
| 2021-07-28 | Meteny Dennis S | Director | Buy | 6 k | 14,64 | 84 k USD |
| 2021-07-28 | Meteny Dennis S | Director | Sell | 3 k | 26,43 | 84 k USD |
| 2021-07-28 | JOHNSON WESLEY | Director | Buy | 6 k | 14,64 | 84 k USD |
| 2021-07-28 | JOHNSON WESLEY | Director | Sell | 3 k | 26,43 | 84 k USD |
| 2021-07-28 | Meteny Dennis S | Director | Buy | 6 k | 14,64 | 84 k USD |
| 2021-07-28 | Meteny Dennis S | Director | Sell | 3 k | 26,43 | 84 k USD |
| 2021-07-26 | Clemmer James C | President and CEO | Sell | 2 k | 26,10 | 55 k USD |
| 2021-07-26 | Trowbridge Stephen A | EVP and CFO | Sell | 353 | 26,10 | 9 k USD |
| 2021-07-26 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 318 | 26,10 | 8 k USD |
| 2021-07-26 | Centea Scott | Sr. VP/GM, Global VIT | Sell | 419 | 26,10 | 11 k USD |
| 2021-07-26 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 318 | 26,10 | 8 k USD |
| 2021-07-26 | Centea Scott | Sr. VP/GM, Global VIT | Sell | 419 | 26,10 | 11 k USD |
| 2021-07-26 | Clemmer James C | President and CEO | Sell | 2 k | 26,10 | 55 k USD |
| 2021-07-26 | Trowbridge Stephen A | EVP and CFO | Sell | 353 | 26,10 | 9 k USD |
| 2021-07-21 | Piccinini Laura | SVP International | Buy | 3 k | 0,00 | 0 USD |
| 2021-07-21 | Piccinini Laura | SVP International | Buy | 3 k | 0,00 | 0 USD |
| 2021-07-21 | ROSENZWEIG RICHARD C | SVP and General Counsel | Buy | 3 k | 0,00 | 0 USD |
| 2021-07-21 | Tarnoff Michael E | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Clemmer James C | President and CEO | Buy | 26 k | 0,00 | 0 USD |
| 2021-07-21 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 4 k | 0,00 | 0 USD |
| 2021-07-21 | Licitra Karen A | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Centea Scott | SVP/GM, VIT | Buy | 3 k | 0,00 | 0 USD |
| 2021-07-21 | Helsel Dave | SVP Global Operations and R&D | Buy | 4 k | 0,00 | 0 USD |
| 2021-07-21 | Meteny Dennis S | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Trowbridge Stephen A | EVP and CFO | Buy | 7 k | 0,00 | 0 USD |
| 2021-07-21 | DONNELLY HOWARD W | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Auen Eileen O'Shea | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | REED JAN STERN | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | JOHNSON WESLEY | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Auen Eileen O'Shea | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 4 k | 0,00 | 0 USD |
| 2021-07-21 | Centea Scott | SVP/GM, VIT | Buy | 3 k | 0,00 | 0 USD |
| 2021-07-21 | Clemmer James C | President and CEO | Buy | 26 k | 0,00 | 0 USD |
| 2021-07-21 | DONNELLY HOWARD W | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Helsel Dave | SVP Global Operations and R&D | Buy | 4 k | 0,00 | 0 USD |
| 2021-07-21 | JOHNSON WESLEY | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Licitra Karen A | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Meteny Dennis S | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | REED JAN STERN | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | ROSENZWEIG RICHARD C | SVP and General Counsel | Buy | 3 k | 0,00 | 0 USD |
| 2021-07-21 | Tarnoff Michael E | Director | Buy | 6 k | 0,00 | 0 USD |
| 2021-07-21 | Trowbridge Stephen A | EVP and CFO | Buy | 7 k | 0,00 | 0 USD |
| 2021-07-18 | Clemmer James C | President and CEO | Sell | 1 k | 24,76 | 37 k USD |
| 2021-07-18 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 300 | 24,76 | 7 k USD |
| 2021-07-18 | Centea Scott | SVP/GM, VIT | Sell | 344 | 24,76 | 9 k USD |
| 2021-07-18 | Helsel Dave | SVP Global Operations and R&D | Sell | 417 | 24,76 | 10 k USD |
| 2021-07-18 | Trowbridge Stephen A | EVP and CFO | Sell | 400 | 24,76 | 10 k USD |
| 2021-07-18 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 300 | 24,76 | 7 k USD |
| 2021-07-18 | Centea Scott | SVP/GM, VIT | Sell | 344 | 24,76 | 9 k USD |
| 2021-07-18 | Clemmer James C | President and CEO | Sell | 1 k | 24,76 | 37 k USD |
| 2021-07-18 | Helsel Dave | SVP Global Operations and R&D | Sell | 417 | 24,76 | 10 k USD |
| 2021-07-18 | Trowbridge Stephen A | EVP and CFO | Sell | 400 | 24,76 | 10 k USD |
| 2021-07-17 | Clemmer James C | President and CEO | Sell | 2 k | 24,76 | 53 k USD |
| 2021-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 262 | 24,76 | 6 k USD |
| 2021-07-17 | Centea Scott | SVP/GM, VIT | Sell | 339 | 24,76 | 8 k USD |
| 2021-07-17 | Helsel Dave | SVP Global Operations and R&D | Sell | 294 | 24,76 | 7 k USD |
| 2021-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 354 | 24,76 | 9 k USD |
| 2021-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 262 | 24,76 | 6 k USD |
| 2021-07-17 | Centea Scott | SVP/GM, VIT | Sell | 339 | 24,76 | 8 k USD |
| 2021-07-17 | Clemmer James C | President and CEO | Sell | 2 k | 24,76 | 53 k USD |
| 2021-07-17 | Helsel Dave | SVP Global Operations and R&D | Sell | 294 | 24,76 | 7 k USD |
| 2021-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 354 | 24,76 | 9 k USD |
| 2021-07-14 | Clemmer James C | President and CEO | Sell | 5 k | 26,43 | 122 k USD |
| 2021-07-14 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 571 | 26,43 | 15 k USD |
| 2021-07-14 | Centea Scott | SVP/GM, VIT | Sell | 500 | 26,43 | 13 k USD |
| 2021-07-14 | Helsel Dave | SVP Global Operations and R&D | Sell | 640 | 26,43 | 17 k USD |
| 2021-07-14 | Trowbridge Stephen A | EVP and CFO | Sell | 1 k | 26,43 | 34 k USD |
| 2021-07-14 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 571 | 26,43 | 15 k USD |
| 2021-07-14 | Centea Scott | SVP/GM, VIT | Sell | 500 | 26,43 | 13 k USD |
| 2021-07-14 | Clemmer James C | President and CEO | Sell | 5 k | 26,43 | 122 k USD |
| 2021-07-14 | Helsel Dave | SVP Global Operations and R&D | Sell | 640 | 26,43 | 17 k USD |
| 2021-07-14 | Trowbridge Stephen A | EVP and CFO | Sell | 1 k | 26,43 | 34 k USD |
| 2021-04-15 | Trowbridge Stephen A | EVP and CFO | Buy | 14 k | 14,07 | 192 k USD |
| 2021-04-15 | Trowbridge Stephen A | EVP and CFO | Sell | 10 k | 24,21 | 244 k USD |
| 2021-04-15 | Trowbridge Stephen A | EVP and CFO | Buy | 14 k | 14,07 | 192 k USD |
| 2021-04-15 | Trowbridge Stephen A | EVP and CFO | Sell | 10 k | 24,21 | 244 k USD |
| 2021-04-14 | Helsel Dave | SVP Global Operations and R&D | Sell | 4 k | 23,93 | 84 k USD |
| 2021-04-14 | Helsel Dave | SVP Global Operations and R&D | Sell | 4 k | 23,93 | 84 k USD |
| 2021-04-01 | DONNELLY HOWARD W | Director | Buy | 6 k | 14,64 | 84 k USD |
| 2021-04-01 | DONNELLY HOWARD W | Director | Sell | 4 k | 23,15 | 84 k USD |
| 2021-04-01 | DONNELLY HOWARD W | Director | Buy | 6 k | 14,64 | 84 k USD |
| 2021-04-01 | DONNELLY HOWARD W | Director | Sell | 4 k | 23,15 | 84 k USD |
| 2021-02-03 | Trowbridge Stephen A | EVP and CFO | Sell | 527 | 19,24 | 10 k USD |
| 2021-02-03 | Trowbridge Stephen A | EVP and CFO | Sell | 527 | 19,24 | 10 k USD |
| 2021-02-01 | ROSENZWEIG RICHARD C | SVP and General Counsel | Buy | 11 k | 0,00 | 0 USD |
| 2021-02-01 | ROSENZWEIG RICHARD C | SVP and General Counsel | Buy | 11 k | 0,00 | 0 USD |
| 2021-01-20 | JOHNSON WESLEY | Director | Sell | 7 k | 18,53 | 120 k USD |
| 2021-01-20 | JOHNSON WESLEY | Director | Sell | 7 k | 18,53 | 120 k USD |
| 2020-12-18 | Helsel Dave | SVP Global Operations and R&D | Sell | 733 | 14,29 | 10 k USD |
| 2020-12-18 | Helsel Dave | SVP Global Operations and R&D | Sell | 733 | 14,29 | 10 k USD |
| 2020-10-31 | Centea Scott | SVP/GM, VIT | Sell | 849 | 10,62 | 9 k USD |
| 2020-10-31 | Centea Scott | SVP/GM, VIT | Sell | 849 | 10,62 | 9 k USD |
| 2020-08-11 | Trowbridge Stephen A | EVP and CFO | Buy | 1 k | 9,38 | 10 k USD |
| 2020-08-11 | Trowbridge Stephen A | EVP and CFO | Buy | 1 k | 9,38 | 10 k USD |
| 2020-07-31 | Clemmer James C | President and CEO | Buy | 40 k | 8,26 | 330 k USD |
| 2020-07-31 | Clemmer James C | President and CEO | Buy | 40 k | 8,26 | 330 k USD |
| 2020-07-27 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 259 | 8,80 | 2 k USD |
| 2020-07-27 | Clemmer James C | President and CEO | Sell | 2 k | 8,80 | 16 k USD |
| 2020-07-27 | Trowbridge Stephen A | EVP and CFO | Sell | 292 | 8,80 | 3 k USD |
| 2020-07-27 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 259 | 8,80 | 2 k USD |
| 2020-07-27 | Clemmer James C | President and CEO | Sell | 2 k | 8,80 | 16 k USD |
| 2020-07-27 | Trowbridge Stephen A | EVP and CFO | Sell | 292 | 8,80 | 3 k USD |
| 2020-07-26 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 283 | 8,80 | 2 k USD |
| 2020-07-26 | Clemmer James C | President and CEO | Sell | 2 k | 8,80 | 17 k USD |
| 2020-07-26 | Trowbridge Stephen A | EVP and CFO | Sell | 314 | 8,80 | 3 k USD |
| 2020-07-26 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 283 | 8,80 | 2 k USD |
| 2020-07-26 | Clemmer James C | President and CEO | Sell | 2 k | 8,80 | 17 k USD |
| 2020-07-26 | Trowbridge Stephen A | EVP and CFO | Sell | 314 | 8,80 | 3 k USD |
| 2020-07-18 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 224 | 9,21 | 2 k USD |
| 2020-07-18 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 76 | 9,21 | 700 USD |
| 2020-07-18 | Clemmer James C | President and CEO | Sell | 1 k | 9,21 | 14 k USD |
| 2020-07-18 | Helsel Dave | SVP Global Operations and R&D | Sell | 207 | 9,21 | 2 k USD |
| 2020-07-18 | Helsel Dave | SVP Global Operations and R&D | Sell | 155 | 9,21 | 1 k USD |
| 2020-07-18 | Trowbridge Stephen A | EVP and CFO | Sell | 248 | 9,21 | 2 k USD |
| 2020-07-18 | Trowbridge Stephen A | EVP and CFO | Sell | 152 | 9,21 | 1 k USD |
| 2020-07-18 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 224 | 9,21 | 2 k USD |
| 2020-07-18 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 76 | 9,21 | 700 USD |
| 2020-07-18 | Clemmer James C | President and CEO | Sell | 1 k | 9,21 | 14 k USD |
| 2020-07-18 | Helsel Dave | SVP Global Operations and R&D | Sell | 207 | 9,21 | 2 k USD |
| 2020-07-18 | Helsel Dave | SVP Global Operations and R&D | Sell | 155 | 9,21 | 1 k USD |
| 2020-07-18 | Trowbridge Stephen A | EVP and CFO | Sell | 248 | 9,21 | 2 k USD |
| 2020-07-18 | Trowbridge Stephen A | EVP and CFO | Sell | 152 | 9,21 | 1 k USD |
| 2020-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 262 | 9,46 | 2 k USD |
| 2020-07-17 | Clemmer James C | President and CEO | Sell | 2 k | 9,46 | 20 k USD |
| 2020-07-17 | Helsel Dave | SVP Global Operations and R&D | Sell | 254 | 9,46 | 2 k USD |
| 2020-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 354 | 9,46 | 3 k USD |
| 2020-07-17 | Campbell Chad Thomas | SVP/GM, Vascular Access | Sell | 262 | 9,46 | 2 k USD |
| 2020-07-17 | Clemmer James C | President and CEO | Sell | 2 k | 9,46 | 20 k USD |
| 2020-07-17 | Helsel Dave | SVP Global Operations and R&D | Sell | 254 | 9,46 | 2 k USD |
| 2020-07-17 | Trowbridge Stephen A | EVP and CFO | Sell | 354 | 9,46 | 3 k USD |
| 2020-07-14 | Tarnoff Michael E | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Tarnoff Michael E | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 7 k | 0,00 | 0 USD |
| 2020-07-14 | Clemmer James C | President and CEO | Buy | 54 k | 0,00 | 0 USD |
| 2020-07-14 | Helsel Dave | SVP Global Operations and R&D | Buy | 8 k | 0,00 | 0 USD |
| 2020-07-14 | Trowbridge Stephen A | EVP and CFO | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Clemmer James C | President and CEO | Buy | 54 k | 0,00 | 0 USD |
| 2020-07-14 | Campbell Chad Thomas | SVP/GM, Vascular Access | Buy | 7 k | 0,00 | 0 USD |
| 2020-07-14 | Helsel Dave | SVP Global Operations and R&D | Buy | 8 k | 0,00 | 0 USD |
| 2020-07-14 | Trowbridge Stephen A | EVP and CFO | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Auen Eileen O'Shea | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | DONNELLY HOWARD W | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Gould Kevin J | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | JOHNSON WESLEY | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Licitra Karen A | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Meteny Dennis S | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | REED JAN STERN | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Auen Eileen O'Shea | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | DONNELLY HOWARD W | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Gould Kevin J | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | JOHNSON WESLEY | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Licitra Karen A | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | Meteny Dennis S | Director | Buy | 15 k | 0,00 | 0 USD |
| 2020-07-14 | REED JAN STERN | Director | Buy | 15 k | 0,00 | 0 USD |